Carbamazepine or levetiracetam: Which one is better in neurocysticercosis?

Saved in:
Bibliographic Details
Title: Carbamazepine or levetiracetam: Which one is better in neurocysticercosis?
Authors: Panda, Prateek Kumar (AUTHOR), Sharawat, Indar Kumar (AUTHOR)
Source: Acta Neurologica Scandinavica. Apr2022, Vol. 145 Issue 4, p484-485. 2p.
Subjects: Neurocysticercosis, Epilepsy, Carbamazepine, Levetiracetam
Abstract: The authors have mentioned most adverse effects of CBZ were minor, but 3 patients had to discontinue the medication due to rash, making the adverse effects severe in grading. Keywords: antiepileptic drugs; antiseizure medications; epilepsy; neurocysticercosis EN antiepileptic drugs antiseizure medications epilepsy neurocysticercosis 484 485 2 03/11/22 20220401 NES 220401 We read with interest the recent article titled "Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis" by Santhosh et al.1 The authors have concluded that carbamazepine (CBZ) and levetiracetam (LEV) could be used as alternatives in newly diagnosed patients of neurocysticercosis (NCC) at the behest of minor side effects in the CBZ group. [Extracted from the article]
Copyright of Acta Neurologica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
Description
Abstract:The authors have mentioned most adverse effects of CBZ were minor, but 3 patients had to discontinue the medication due to rash, making the adverse effects severe in grading. Keywords: antiepileptic drugs; antiseizure medications; epilepsy; neurocysticercosis EN antiepileptic drugs antiseizure medications epilepsy neurocysticercosis 484 485 2 03/11/22 20220401 NES 220401 We read with interest the recent article titled "Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis" by Santhosh et al.1 The authors have concluded that carbamazepine (CBZ) and levetiracetam (LEV) could be used as alternatives in newly diagnosed patients of neurocysticercosis (NCC) at the behest of minor side effects in the CBZ group. [Extracted from the article]
ISSN:00016314
DOI:10.1111/ane.13424